Evans Fernandez Perez: Clinical Trials

1 trial sponsored by Evans Fernandez Perez, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Evans Fernandez Perez: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Efficacy and Safety of Pirfenidone in Patients With Fibrotic Hypersensitivity Pneumonitis
Pirfenidone, Placebo controlled - Interstitial Lung Disease
Phase 2TerminatedEvans Fernandez Perez402017-06-052023-01-09

Conditions studied

Lung Diseases, Interstitial (1)

Interventions

pirfenidone (1)

Countries

United States (1)

Results publications

PMID 34109243, PMID 37028940, PMID 38641768